MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...

clang-uml is an automatic C++ to UML class, sequence, package and include diagram generator, driven by YAML configuration files. The main idea behind the project is to easily maintain up-to-date ...